Nurix Therapeutics is Part of a Team of International Oncology Experts Selected as Cancer Grand Challenges Awardees to Address Pediatric Cancers Using Targeted Protein Degradation (TPD)

25.03.2024 - Researchers will apply the latest TPD drug discovery technology to target fusion proteins that cause pediatric cancer Cancer Grand Challenges is an initiative funded by Cancer Research UK SAN FRANCISCO, March 25, 2024 (GLOBE NEWSWIRE) - Nurix ... Seite 1

Related Keywords

France ,Philadelphia ,Pennsylvania ,United States ,United Kingdom ,Germany ,Austria ,Gwennm Hansen ,Yael Moss ,Martin Eilers ,Neuroblastoma Research ,Nurix Therapeutics Inc ,Nasdaq ,Cancer Grand Challenges ,Patricia Brophy Endowed Chair ,Molecular Biology ,Out Oncogenic Drivers ,Curing Childhood ,